3Birouk N, Gouider R, Guern EL, et aL Charcot-Marie-Tooth desease 1A with 17pl 1.2 duplication: linical and electrophysiological phenotype study and factorsin fluencing disease severity in 119 cases. Brain 1997: 120:813 -23.
4Pfeiffer G, Wicklein EM," Ratusinski T, et al. Disability and quality of life in Charcot-Marie-Tooth disease type 1. J Neurol Neurosurg Psychiatry 2001; 70:548 -50.
5MacMillan JC, Harper IS, The Charcot-Marie-Tooth syndrome: perceptions of disability and projected use of DNA diagnostic tests. Clin Genet 1992; 42:161 -3.
6Bird TD, Kraft GH, Lipe HP, et al. Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study. Ann Neurol 1997; 41:463 - 9.
7Teunissen LL, Notermans NC, Franssen H, et aL Disease course of Charcot-Marie-Tooth disease type Ⅱ. Arch Neurol 2003; 60:823 -8.
8Hattori N, Yarnamoto M, Yoshihara T, et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins(PMP22,MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain 2003: 126:134 -51.
9Veiny C, Ravise N, Leutenegger AL, et al. Coincidence of two genetic forms of Charcot-Marie-Tooth disease in a single family. Neurology 2004; 63 (8): 1527 -9.
